Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,151,452
+$316,301 QoQ
Shares Held
960
+5.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#3,005
of 4,605 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Investment Advisory Group, LLC holds $4,804,990 across 6 Drug Manufacturers - General names. LLY ranks #2 (24.0% of the industry book) .
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,151,452 | 960 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $835,151 | 908 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $939,270 | 874 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $660,758 | 866 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $675,852 | 867 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $698,719 | 846 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $592,124 | 767 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $676,858 | 764 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $564,957 | 624 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $484,669 | 623 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $357,912 | 614 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $335,706 | 625 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $284,201 | 606 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $203,991 | 594 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $217,308 | 594 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $218,907 | 677 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $219,503 | 677 | Shares | Sole | 2022-07-18 | |
| No filing history on record for this holder in this stock. | ||||||